questions to ask before starting glp 1 5 YOUR PROVIDER A GLP1! GLP-1: Miracle, Myth, or Metabolic

Final Recommendation: Which Platform Offers Better Value

Although the reduction in risk for HS complications was not as large among those with type 2 diabetes, researchers observed similar reductions in the rates of surgeries (HR = 0.25

In addition, GLP-1 analogue treatment reduced all-cause mortality by 12%, hospital admission for heart failure by 9%, and a broad composite kidney outcome (development of new-onset macroalbuminuria, decline in estimated glomerular filtration rate [or increase in creatinine], progression to end-stage kidney disease, or death attributable to kidney causes) by 17%, mainly due to a reduction in urinary albumin excretion [27]

In 2025, Eli Lilly announced a $27 billion U.S